Singapore Expands MediSave and Reforms Integrated Shield Plan Riders as Medical Inflation Climbs

Singapore is enacting a wave of healthcare-financing reforms in 2026 designed to expand coverage while containing the surge in medical costs that has become one of the most pressing challenges for the city-state's insurance sector. The changes touch both the national health insurance system and the private Integrated Shield Plan (IP) market.

On the coverage-expansion side, from June 2026, MediSave and MediShield Life — Singapore's national medical savings and insurance schemes — will cover the surgical and pre- and post-procedure costs of fertility-preservation procedures, including embryo freezing, egg freezing, and ovarian tissue freezing. This reflects a deliberate policy priority to support families seeking to have children, complementing other 2026 changes such as doubling the annual MediSave withdrawal cap for outpatient scans from S$300 to S$600 (effective January 1, 2026) and expanding Flexi-MediSave to cover restorative dental procedures for seniors aged 60 and above.

On the cost-containment side, the Ministry of Health (MOH) has rolled out a new framework for IP riders — the optional add-ons to Integrated Shield Plans that provide coverage on top of MediShield Life. The new framework, aimed at curbing rising healthcare bills, has produced dramatic premium reductions: new IP rider premiums are at least 30% lower, with one insurer offering a reduction of up to 84%. These changes are intended to make supplementary private health coverage more affordable and sustainable while addressing concerns that overly generous riders had contributed to over-consumption of healthcare services and escalating claims costs.

The reforms come against a backdrop of intense medical-cost pressure. Medical inflation in Singapore is expected to climb roughly 16.9% in 2026, dramatically outpacing general inflation, driven by more expensive medical equipment, advanced treatments, and rising labour costs. Across the Asia-Pacific region, medical costs are projected to rise 14% in 2026, and globally 10.3%. The Life Insurance Association Singapore has emphasised that consistent efforts are needed to ensure the long-term sustainability of healthcare insurance. For Singapore's insurers — including major players like Great Eastern, Prudential, AIA, and Singlife — the dual challenge is offering attractive, affordable products to consumers while managing the claims inflation that threatens underwriting profitability in the health segment.